Fibrotic disease and the TH1/TH2 paradigm
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, interferon-γ (IFNγ), produced by many immune cells including NK, NKT and T cells, has direct anti-fibrogenic activity on HSCs (70–72).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredIn the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Normally, myofibroblasts carefully coordinate the breakdown of granulation tissue and replacement with long-lasting type I collagen [100].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“However, it is now described as a general immunosuppressive cytokine that downregulates chronic inflammatory responses through many mechanism”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Cited by
Items 101–200 of 1,000
Mouse models of graft-versus-host disease: advances and limitations
Schroeder, M. A., & DiPersio, J. F. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006668 · Cited by 291
“The pathology is dependent on CD4+ T cells that release Th2 cytokines, which can stimulate other cells to release fibrosing cytokines (such as IL-13 and TGF) (for a review, see Wynn, 2004), resulting in the sclerodermatous changes (Hamilton, 1987; Korngold and Sprent, 1987).”
BackgroundMantovani, A., & Locati, M. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.300168 · Cited by 290
Pathological mechanisms and therapeutic outlooks for arthrofibrosis
Usher, K. M., Zhu, S., Mavropalias, G., Carrino, J. A., Zhao, J., & Xu, J. (2019) · Bone Research · doi:10.1038/s41413-019-0047-x · Cited by 285
Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis
Kisseleva, T., & Brenner, D. A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04658.x · Cited by 286
The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
Hammouda, M., Ford, A., Liu, Y., & Zhang, J. (2020) · Cells · doi:10.3390/cells9040857 · Cited by 284
Hepatic stellate cells and the reversal of fibrosis
Kisseleva, T., & Brenner, D. A. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04584.x · Cited by 278
Yamauchi, M., Barker, T. H., Gibbons, D. L., & Kurie, J. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93554 · Cited by 270
Loke, P., Gallagher, I., Nair, M. G., Zang, X., Brombacher, F., Mohrs, M., Allison, J. P., & Allen, J. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3926 · Cited by 274
Nair, M. G., Du, Y., Perrigoue, J. G., Zaph, C., Taylor, J. J., Goldschmidt, M., Swain, G. P., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082048 · Cited by 274
Agrawal, A. S., Tao, X., Algaissi, A., Garron, T., Narayanan, K., Peng, B.-H., Couch, R. B., & Tseng, C.-T. K. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1177688 · Cited by 274
Cellular and molecular mechanisms of intestinal fibrosis
Speca, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i28.3635 · Cited by 272
Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation
Shao, D. D., Suresh, R., Vakil, V., Gomer, R. H., & Pilling, D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107782 · Cited by 272
Allen, J. E., & Sutherland, T. E. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.06.003 · Cited by 263
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Cytlak, U. M., Dyer, D. P., Honeychurch, J., Williams, K. J., Travis, M. A., & Illidge, T. M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00568-1 · Cited by 258
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans
Hillebrandt, S., Wasmuth, H. E., Weiskirchen, R., Hellerbrand, C., Keppeler, H., Werth, A., Schirin-Sokhan, R., Wilkens, G., Geier, A., Lorenzen, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1599 · Cited by 258
Revisiting fibrosis in inflammatory bowel disease: the gut thickens
D’Alessio, S., Ungaro, F., Noviello, D., Lovisa, S., Peyrin-Biroulet, L., & Danese, S. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00543-0 · Cited by 253
Fibrinogen drives dystrophic muscle fibrosis via a TGFβ/alternative macrophage activation pathway
Vidal, B., Serrano, A. L., Tjwa, M., Suelves, M., Ardite, E., De Mori, R., Baeza-Raja, B., Martínez de Lagrán, M., Lafuste, P., Ruiz-Bonilla, V., et al. (2008) · Genes & Development · doi:10.1101/gad.465908 · Cited by 257
“Alternatively activated macrophages (as opposed to classically activated, proinflammatory macrophages) have been associated with certain fibrotic pathologies (Wynn 2004).”
BackgroundPulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis
Oikonomou, N., Mouratis, M.-A., Tzouvelekis, A., Kaffe, E., Valavanis, C., Vilaras, G., Karameris, A., Prestwich, G. D., Bouros, D., & Aidinis, V. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0004oc · Cited by 250
Inflammation activation and resolution in human tendon disease
Dakin, S. G., Martinez, F. O., Yapp, C., Wells, G., Oppermann, U., Dean, B. J. F., Smith, R. D. J., Wheway, K., Watkins, B., Roche, L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4269 · Cited by 253
“Macrophages expressing CD206 are frequently associated with the repair and remodeling of healing tissues (50) and have also been identified in healing equine digital flexor tendons (18).”
BackgroundInterleukin-33 overexpression is associated with liver fibrosis in mice and humans
Marvie, P., Lisbonne, M., L’Helgoualc’h, A., Rauch, M., Turlin, B., Preisser, L., Bourd‐Boittin, K., Théret, N., Gascan, H., Piquet‐Pellorce, C., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00801.x · Cited by 251
Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy
Kharraz, Y., Guerra, J., Pessina, P., Serrano, A. L., & Muñoz-Cánoves, P. (2014) · BioMed Research International · doi:10.1155/2014/965631 · Cited by 251
El Kasmi, K. C., Pugliese, S. C., Riddle, S. R., Poth, J. M., Anderson, A. L., Frid, M. G., Li, M., Pullamsetti, S. S., Savai, R., Nagel, M. A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303048 · Cited by 245
Amino acid auxotrophy as a system of immunological control nodes
Murray, P. J. (2016) · Nature Immunology · doi:10.1038/ni.3323 · Cited by 249
Management of keloids and hypertrophic scars: current and emerging options
Gauglitz, G. (2013) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s35252 · Cited by 248
Characterization of time-related changes after experimental bile duct ligation
Georgiev, P., Jochum, W., Heinrich, S., Jang, J. H., Nocito, A., Dahm, F., & Clavien, P.-A. (2008) · British Journal of Surgery · doi:10.1002/bjs.6050 · Cited by 249
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia
Fibbi, B., Penna, G., Morelli, A., Adorini, L., & Maggi, M. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.00972.x · Cited by 242
Multi-omic analysis reveals divergent molecular events in scarring and regenerative wound healing
Mascharak, S., Talbott, H. E., Januszyk, M., Griffin, M., Chen, K., Davitt, M. F., Demeter, J., Henn, D., Bonham, C. A., Foster, D. S., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2021.12.011 · Cited by 240
“Collectively, fibroses are implicated in 45% of all deaths in the U.S. (Wynn, 2004).”
BackgroundLysoglycerophospholipids in chronic inflammatory disorders: The PLA2/LPC and ATX/LPA axes
Sevastou, I., Kaffe, E., Mouratis, M.-A., & Aidinis, V. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.019 · Cited by 241
Fibrosis: ultimate and proximate causes
Thannickal, V. J., Zhou, Y., Gaggar, A., & Duncan, S. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74368 · Cited by 242
“Since fibrosis is a predominant feature of the pathology of a wide range of diseases across multiple organ systems, fibrotic disorders have been estimated to contribute to an estimated 45% of all-cause mortality in the United States (1).”
BackgroundFuture Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
Blackwell, T. S., Tager, A. M., Borok, Z., Moore, B. B., Schwartz, D. A., Anstrom, K. J., Bar-Joseph, Z., Bitterman, P., Blackburn, M. R., Bradford, W., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1141ws · Cited by 236
Self-citationMorphometric and Visual Evaluation of Fibrosis in Renal Biopsies
Farris, A. B., Adams, C. D., Brousaides, N., Della Pelle, P. A., Collins, A. B., Moradi, E., Smith, R. N., Grimm, P. C., & Colvin, R. B. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009091005 · Cited by 231
Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis
Kotsianidis, I., Nakou, E., Bouchliou, I., Tzouvelekis, A., Spanoudakis, E., Steiropoulos, P., Sotiriou, I., Aidinis, V., Margaritis, D., Tsatalas, C., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1936oc · Cited by 230
The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
Murtha, L. A., Schuliga, M. J., Mabotuwana, N. S., Hardy, S. A., Waters, D. W., Burgess, J. K., Knight, D. A., & Boyle, A. J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00777 · Cited by 229
“Further studies suggest Th1 cells control activation, migration and differentiation of macrophages, and macrophage dependent monocyte chemoattractant protein-1 expression, leading to further inflammation and fibrosis (Wynn, 2004; Han et al., 2012; Van Linthout et al., 2014).”
BackgroundThe IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets
Nguyen, J. K., Austin, E., Huang, A., Mamalis, A., & Jagdeo, J. (2020) · Archives of Dermatological Research · doi:10.1007/s00403-019-01972-3 · Cited by 226
Role of Galectin-3 in Human Pulmonary Fibrosis
Nishi, Y., Sano, H., Kawashima, T., Okada, T., Kuroda, T., Kikkawa, K., Kawashima, S., Tanabe, M., Goto, T., Matsuzawa, Y., et al. (2007) · Allergology International · doi:10.2332/allergolint.o-06-449 · Cited by 226
Immunology of IgG4-related disease
Della-Torre, E., Lanzillotta, M., & Doglioni, C. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12641 · Cited by 226
Macrophages and fibroblasts during inflammation and tissue repair in models of organ regeneration
Mescher, A. L. (2017) · Regeneration · doi:10.1002/reg2.77 · Cited by 224
“Specific populations of lymphocytes, the effector cells of adaptive immunity activatedbymonocyte-derived antigen-presenting cells during inflammation, are also clearly involved in mammalian tissue fibrosis (scarring) and fibrotic disorders (Wynn, 2004).”
BackgroundCancer-associated secondary lymphoedema
Rockson, S. G., Keeley, V., Kilbreath, S., Szuba, A., & Towers, A. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0072-5 · Cited by 218
Mesenchymal stromal cell therapy for liver diseases
Alfaifi, M., Eom, Y. W., Newsome, P. N., & Baik, S. K. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.030 · Cited by 217
“10 production of ECM in the liver [57-60].”
BackgroundRetnla (Relmα/Fizz1) Suppresses Helminth-Induced Th2-Type Immunity
Pesce, J. T., Ramalingam, T. R., Wilson, M. S., Mentink-Kane, M. M., Thompson, R. W., Cheever, A. W., Urban, J. F., & Wynn, T. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000393 · Cited by 213
Self-citationWhyte, C. S., Bishop, E. T., Rückerl, D., Gaspar-Pereira, S., Barker, R. N., Allen, J. E., Rees, A. J., & Wilson, H. M. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1110644 · Cited by 215
Hasegawa, M., Hamaguchi, Y., Yanaba, K., Bouaziz, J.-D., Uchida, J., Fujimoto, M., Matsushita, T., Matsushita, Y., Horikawa, M., Komura, K., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060205 · Cited by 215
“A relative shift to Th2 rather than Th1 cytokines can also induce tissue fibrosis.(56) Likewise, blocking IL-4 function inhibits skin fibrosis in newborn Tsk mice,(27,34) whereas IL-12 production can prevent sclerosis and autoimmunity in Tsk mice.”
BackgroundMacrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis
Wen, J.-H., Li, D.-Y., Liang, S., Yang, C., Tang, J.-X., & Liu, H.-F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.946832 · Cited by 210
“As a leading cause of morbidity and mortality, fibrosis is the common pathway of various chronic inflammatory diseases in organs and causes a nearly 50% death rate in patients in developed countries (1, 2).”
BackgroundIron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype
Maus, M., López-Polo, V., Mateo, L., Lafarga, M., Aguilera, M., De Lama, E., Meyer, K., Sola, A., Lopez-Martinez, C., López-Alonso, I., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00928-2 · Cited by 215
Kramann, R., DiRocco, D. P., & Humphreys, B. D. (2013) · The Journal of Pathology · doi:10.1002/path.4253 · Cited by 211
“Novartis is developing an antibody to inhibit IL-13, known as QAX576, and is currently running trials in Crohn’s disease and has completed trials in patients with IPF, which unfortunately failed.”
BackgroundInfluentialThe Bigger Picture: Why Oral Mucosa Heals Better Than Skin
Waasdorp, M., Krom, B. P., Bikker, F. J., van Zuijlen, P. P. M., Niessen, F. B., & Gibbs, S. (2021) · Biomolecules · doi:10.3390/biom11081165 · Cited by 207
CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages
Meziani, L., Mondini, M., Petit, B., Boissonnas, A., Thomas de Montpreville, V., Mercier, O., Vozenin, M.-C., & Deutsch, E. (2018) · European Respiratory Journal · doi:10.1183/13993003.02120-2017 · Cited by 208
Trivedi, A., Olivas, A. D., & Noble-Haeusslein, L. J. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.007 · Cited by 205
The immune network in pancreatic cancer development and progression
Wörmann, S. M., Diakopoulos, K. N., Lesina, M., & Algül, H. (2014) · Oncogene · doi:10.1038/onc.2013.257 · Cited by 205
Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity
Reiman, R. M., Thompson, R. W., Feng, C. G., Hari, D., Knight, R., Cheever, A. W., Rosenberg, H. F., & Wynn, T. A. (2006) · Infection and Immunity · doi:10.1128/iai.74.3.1471-1479.2006 · Cited by 206
Self-citationCurrent and upcoming therapies to modulate skin scarring and fibrosis
Coentro, J. Q., Pugliese, E., Hanley, G., Raghunath, M., & Zeugolis, D. I. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.009 · Cited by 204
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Oncotarget · doi:10.18632/oncotarget.21234 · Cited by 204
Macrophage polarization: a key event in the secondary phase of acute spinal cord injury
Kong, X., & Gao, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13034 · Cited by 202
Novel therapeutic approaches for pulmonary fibrosis
Datta, A., Scotton, C. J., & Chambers, R. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01247.x · Cited by 202
“The Th hypothesis of fibrosis proposes that progressive pulmonary fibrosis results from a maladaptive immune response, dominated by Th2 cytokines, such as interleukin (IL)-13, to a persistent inciting agent [reviewed in (Wynn, 2004)].”
BackgroundDynamic Mast Cell–Stromal Cell Interactions Promote Growth of Pancreatic Cancer
Ma, Y., Hwang, R. F., Logsdon, C. D., & Ullrich, S. E. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4479 · Cited by 186
Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
Lu, Q., Yang, M.-F., Liang, Y.-J., Xu, J., Xu, H.-M., Nie, Y.-Q., Wang, L.-S., Yao, J., & Li, D.-F. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s353038 · Cited by 200
T cell costimulation blockade blunts pressure overload-induced heart failure
Kallikourdis, M., Martini, E., Carullo, P., Sardi, C., Roselli, G., Greco, C. M., Vignali, D., Riva, F., Ormbostad Berre, A. M., Stølen, T. O., et al. (2017) · Nature Communications · doi:10.1038/ncomms14680 · Cited by 199
Cellular and Molecular Mechanisms Regulating Fibrosis in Skeletal Muscle Repair and Disease
Serrano, A. L., Mann, C. J., Vidal, B., Ardite, E., Perdiguero, E., & Muñoz-Cánoves, P. (2011) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-385940-2.00007-3 · Cited by 200
“Similarly to macrophages, Th lymphocytes can differentiate into different functional subsets, namely Th1 and Th2 cells which are able to orchestrate the host-response via distinct profiles of cytokine production (Wynn, 2004).”
BackgroundIntegrated spatial multiomics reveals fibroblast fate during tissue repair
Foster, D. S., Januszyk, M., Yost, K. E., Chinta, M. S., Gulati, G. S., Nguyen, A. T., Burcham, A. R., Salhotra, A., Ransom, R. C., Henn, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110025118 · Cited by 196
Inflammatory cytokines in pulmonary hypertension
Groth, A., Vrugt, B., Brock, M., Speich, R., Ulrich, S., & Huber, L. C. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-47 · Cited by 197
Kahloon, R. A., Xue, J., Bhargava, A., Csizmadia, E., Otterbein, L., Kass, D. J., Bon, J., Soejima, M., Levesque, M. C., Lindell, K. O., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0506oc · Cited by 190
“Antigen(or autoantigen-) activated T cells can cause severe injuries, both directly and/or by production of mediators that activate and recruit other leukocyte, epithelial, and mesenchymal effectors, and these lymphocytes are implicated as the initiation of many diseaseassociated inflammatory cascades (28, 29, 41, 42).”
BackgroundInfectious disease, the innate immune response, and fibrosis
Meneghin, A., & Hogaboam, C. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30595 · Cited by 194
Yamazaki, S., Bonito, A. J., Spisek, R., Dhodapkar, M., Inaba, K., & Steinman, R. M. (2007) · Blood · doi:10.1182/blood-2007-05-088831 · Cited by 194
Activation of Alveolar Macrophages via the Alternative Pathway in Herpesvirus-Induced Lung Fibrosis
Mora, A. L., Torres-González, E., Rojas, M., Corredor, C., Ritzenthaler, J., Xu, J., Roman, J., Brigham, K., & Stecenko, A. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0121oc · Cited by 190
Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment
Rodrigues, K. S., Oliveira-Ribeiro, C., Gomes, S. D. A. F., & Knobler, R. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0306-9 · Cited by 191
Monocytes and Macrophages as Cellular Targets in Liver Fibrosis
Heymann, F., Trautwein, C., & Tacke, F. (2009) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152809789352230 · Cited by 189
Macrophages are necessary for epimorphic regeneration in African spiny mice
Simkin, J., Gawriluk, T. R., Gensel, J. C., & Seifert, A. W. (2017) · eLife · doi:10.7554/elife.24623 · Cited by 189
“Similarly, chronic inflammation leads to compromised healing and fibrotic disease (Martin and Leibovich, 2005; Riches, 1988; Wynn, 2004).”
BackgroundVannella, K. M., Ramalingam, T. R., Borthwick, L. A., Barron, L., Hart, K. M., Thompson, R. W., Kindrachuk, K. N., Cheever, A. W., White, S., Budelsky, A. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1938 · Cited by 188
“In addition to suppressing the proinflammatory activity of type 1 immune responses (2), type 2 immunity regulates wound healing (3), metabolic homeostasis (4), and immunity to several extracellular parasites (5).”
BackgroundSelf-citationKeloids and Hypertrophic Scars: A Spectrum of Clinical Challenges
Trace, A. P., Enos, C. W., Mantel, A., & Harvey, V. M. (2016) · American Journal of Clinical Dermatology · doi:10.1007/s40257-016-0175-7 · Cited by 187
“Interestingly, the TH1 response, mainly via IFN-c, attenuates tissue fibrosis [76].”
BackgroundInterferon-γ Signaling Inhibition Ameliorates Angiotensin II–Induced Cardiac Damage
Markó, L., Kvakan, H., Park, J.-K., Qadri, F., Spallek, B., Binger, K. J., Bowman, E. P., Kleinewietfeld, M., Fokuhl, V., Dechend, R., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.199265 · Cited by 184
FOXM1 (Forkhead box M1) in Tumorigenesis
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 184
“First, resident stromal fibroblasts in the lung, that is, local mesen- chymal cells, can proliferate and transdifferentiate into myofibroblasts (Desmouliere et al., 2005; Hinz et al., 2007; Phan, 2012; Wynn, 2004; Wynn and Barron, 2010).”
BackgroundRamalingam, T. R., Pesce, J. T., Sheikh, F., Cheever, A. W., Mentink-Kane, M. M., Wilson, M. S., Stevens, S., Valenzuela, D. M., Murphy, A. J., Yancopoulos, G. D., et al. (2008) · Nature Immunology · doi:10.1038/ni1544 · Cited by 183
“Total serum IgE was measured with capture antibody to mouse IgE (R35-72) and biotinylated detection antibody to mouse IgE (R35-118), with a recombinant IgE standard curve (27-74).”
MethodSelf-citationInterleukin-13 Signaling and Its Role in Asthma
Rael, E. L., & Lockey, R. F. (2011) · World Allergy Organization Journal · doi:10.1097/wox.0b013e31821188e0 · Cited by 183
The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
Lawrence, J., & Nho, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030778 · Cited by 183
Functional Diversity of T-Cell Subpopulations in Subacute and Chronic Hypersensitivity Pneumonitis
Barrera, L., Mendoza, F., Zuñiga, J., Estrada, A., Zamora, A. C., Melendro, E. I., Ramírez, R., Pardo, A., & Selman, M. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-093oc · Cited by 182
Metabolic Profiling Regarding Pathogenesis of Idiopathic Pulmonary Fibrosis
Kang, Y. P., Lee, S. B., Lee, J.-M., Kim, H. M., Hong, J. Y., Lee, W. J., Choi, C. W., Shin, H. K., Kim, D.-J., Koh, E. S., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00156 · Cited by 179
The Transcription Factor FOXM1 (Forkhead box M1)
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 176
Semaphorin 7A plays a critical role in TGF-β1–induced pulmonary fibrosis
Kang, H.-R., Lee, C. G., Homer, R. J., & Elias, J. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061273 · Cited by 176
Hill, C., Li, J., Liu, D., Conforti, F., Brereton, C. J., Yao, L., Zhou, Y., Alzetani, A., Chee, S. J., Marshall, B. G., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1820-x · Cited by 175
Zhao, J., Zhang, Z., Luan, Y., Zou, Z., Sun, Y., Li, Y., Jin, L., Zhou, C., Fu, J., Gao, B., et al. (2014) · Hepatology · doi:10.1002/hep.26916 · Cited by 174
Molecular and tissue alterations of collagens in fibrosis
Ricard-Blum, S., Baffet, G., & Théret, N. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.004 · Cited by 173
Coinfection With HIV-1 and HCV—A One-Two Punch
Kim, A. Y., & Chung, R. T. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.040 · Cited by 172
Progressive pulmonary fibrosis is mediated by TGF-β isoform 1 but not TGF-β3
Ask, K., Bonniaud, P., Maass, K., Eickelberg, O., Margetts, P. J., Warburton, D., Groffen, J., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.016 · Cited by 172
“Discussion TGF-β is a key cytokine in the pathogenesis of fibroproliferative disorders of the lung, kidney, liver, or skin (Wynn, 2004).”
BackgroundWilliams, S. M., Golden-Mason, L., Ferguson, B. S., Schuetze, K. B., Cavasin, M. A., Demos-Davies, K., Yeager, M. E., Stenmark, K. R., & McKinsey, T. A. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.013 · Cited by 171
Cellular and molecular pathology of HTS: basis for treatment
Armour, A., Scott, P. G., & Tredget, E. E. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00219.x · Cited by 171
Strategies targeting the IL-4/IL-13 axes in disease
May, R. D., & Fung, M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.018 · Cited by 166
Current Concepts on the Pathogenesis of Systemic Sclerosis
Truchetet, M. E., Brembilla, N. C., & Chizzolini, C. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08889-8 · Cited by 170
Dorhoi, A., Reece, S. T., & Kaufmann, S. H. E. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00994.x · Cited by 168
Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
Jeong, H., Hwang, I., Kang, S. H., Shin, H. C., & Kwon, S. Y. (2019) · Journal of Breast Cancer · doi:10.4048/jbc.2019.22.e5 · Cited by 169
The immunomodulatory properties of mesenchymal stem cells
Marigo, I., & Dazzi, F. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0267-7 · Cited by 162
Letavernier, E., Perez, J., Bellocq, A., Mesnard, L., de Castro Keller, A., Haymann, J.-P., & Baud, L. (2008) · Circulation Research · doi:10.1161/circresaha.107.160077 · Cited by 168
Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies
Li, J.-T., Liao, Z.-X., Ping, J., Xu, D., & Wang, H. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2180-y · Cited by 167
Qualls, J. E., Neale, G., Smith, A. M., Koo, M.-S., DeFreitas, A. A., Zhang, H., Kaplan, G., Watowich, S. S., & Murray, P. J. (2010) · Science Signaling · doi:10.1126/scisignal.2000955 · Cited by 167
“In addition, downstreammetabolites that are produced byArg1-mediatedmetabolism of L-arginine have roles in cell division, collagen synthesis, and wound healing (29).”
BackgroundInflammatory manifestations of lymphedema
Ly, C., Kataru, R., & Mehrara, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010171 · Cited by 164
“T helper 1 (Th1) and T h lper 2 (Th2) paradigm, ostulating that pro-fibrotic cytokines and growth factors elaborated by T 2 cells, including interleukin 4 (IL-4), IL-13, and TGF-β1, regu ate collagen deposition and fibrosis in wi ely disparate p hologies [49,50].”
BackgroundResultFibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer
Zhang, H., Maric, I., DiPrima, M. J., Khan, J., Orentas, R. J., Kaplan, R. N., & Mackall, C. L. (2013) · Blood · doi:10.1182/blood-2012-08-449413 · Cited by 163
Madala, S. K., Pesce, J. T., Ramalingam, T. R., Wilson, M. S., Minnicozzi, S., Cheever, A. W., Thompson, R. W., Mentink-Kane, M. M., & Wynn, T. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903008 · Cited by 162
Self-citationIntestinal fibrosis in inflammatory bowel disease — Current knowledge and future perspectives
Rieder, F., & Fiocchi, C. (2008) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2008.05.009 · Cited by 162
CNS Repair Requires Both Effector and Regulatory T Cells with Distinct Temporal and Spatial Profiles
Raposo, C., Graubardt, N., Cohen, M., Eitan, C., London, A., Berkutzki, T., & Schwartz, M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0076-14.2014 · Cited by 161
“…kinetics of both infiltrating mo-M s and CD4 T cells at the injured parenchyma following SCI. Similar to the wound healing response outside the CNS (Wynn, 2004; Shechter et al., 2013), infiltration of CD4 T cells to the lesion parenchyma was found to occur following the wave of infiltrating mo-M s…”
BackgroundPlasma B Lymphocyte Stimulator and B Cell Differentiation in Idiopathic Pulmonary Fibrosis Patients
Xue, J., Kass, D. J., Bon, J., Vuga, L., Tan, J., Csizmadia, E., Otterbein, L., Soejima, M., Levesque, M. C., Gibson, K. F., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203476 · Cited by 161
“In turn, Ag (or autoantigen)-stimulated T cells produce myriad pathogenic mediators (48), and have been singularly implicated as the initiators of many disease-associated inflammatory cascades, including those that result in pathological fibrosis (41, 48, 49).”
BackgroundTGFβ signalling plays an important role in IL4-induced alternative activation of microglia
Zhou, X., Spittau, B., & Krieglstein, K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-210 · Cited by 159
Metadata
- Authors
- Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Nature Reviews Immunology
- Published
- 2004-08
- Volume
- 4
- Issue
- 8
- Pages
- 583-594
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2702150
- OpenAlex
- W1983357763
- Cited by
- 1,765
- References
- 135
- Citations by year
- 2026: 46 · 2025: 76 · 2024: 93 · 2023: 104 · 2022: 126 · 2021: 96 · 2020: 99 · 2019: 83 · 2018: 91 · 2017: 95 · 2016: 87 · 2015: 91 · 2014: 94 · 2013: 82 · 2012: 75
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI001019, Z01AI000829)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- fibrosis, fibrogenesis, Th1/Th2 paradigm, T helper cells, idiopathic pulmonary fibrosis, liver fibrosis, systemic sclerosis, wound healing, fibroproliferative disorders
- MeSH terms
- Animals, Fibroblasts, Fibrosis, Humans, Macrophages, Transforming Growth Factor beta, Th1 Cells, Th2 Cells, Interleukin-13, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.